» Articles » PMID: 28190938

Elucidation of the Anti-Inflammatory Mechanisms of Bupleuri and Scutellariae Radix Using System Pharmacological Analyses

Overview
Publisher Wiley
Specialties Biochemistry
Pathology
Date 2017 Feb 14
PMID 28190938
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

This study was aimed at elucidating the molecular mechanisms underlying the anti-inflammatory effect of the combined application of Bupleuri Radix and Scutellariae Radix and explored the potential therapeutic efficacy of these two drugs on inflammation-related diseases. After searching the databases, we collected the active ingredients of Bupleuri Radix and Scutellariae Radix and calculated their oral bioavailability (OB) and drug-likeness (DL) based on the absorption-distribution-metabolism-elimination (ADME) model. In addition, we predicted the drug targets of the selected active components based on weighted ensemble similarity (WES) and used them to construct a drug-target network. Gene ontology (GO) analysis and KEGG mapper tools were performed on these predicted target genes. We obtained 30 compounds from Bupleuri Radix and Scutellariae Radix of good quality as indicated by ADME assays, which possess potential pharmacological activity. These 30 ingredients have a total of 121 potential target genes, which are involved in 24 biological processes related to inflammation. Combined application of Bupleuri Radix and Scutellariae Radix was found not only to directly inhibit the synthesis and release of inflammatory cytokines, but also to have potential therapeutic effects against inflammation-induced pain. In addition, a combination therapy of these two drugs exhibited systemic treatment efficacy and provided a theoretical basis for the development of drugs against inflammatory diseases.

Citing Articles

A potential Chinese medicine monomer against influenza A virus and influenza B virus: isoquercitrin.

Luo R, Lv C, Wang T, Deng X, Sima M, Guo J Chin Med. 2023; 18(1):144.

PMID: 37919750 PMC: 10621105. DOI: 10.1186/s13020-023-00843-4.


Systematic Screening of the Chemical Constituents of Lanqin Oral Liquid by Ultra-High-Performance Liquid Chromatography Combined with Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.

Liu T, Lin S Molecules. 2023; 28(20).

PMID: 37894534 PMC: 10608861. DOI: 10.3390/molecules28207053.


A network pharmacological approach to investigate the pharmacological effects of CZ2HF decoction on Alzheimer's disease.

Wei Y, Gao J, Xu F, Shi J, Yu C, Gong Q Ibrain. 2023; 7(3):153-170.

PMID: 37786799 PMC: 10529192. DOI: 10.1002/j.2769-2795.2021.tb00080.x.


Anti-inflammatory effects of Chaishi Tuire Granules on influenza A treatment by mediating TRAF6/MAPK14 axis.

Wang L, Guo J, Wang Y, Zhao P, Liu B, Zhang Y Front Med (Lausanne). 2022; 9:943681.

PMID: 36452894 PMC: 9701735. DOI: 10.3389/fmed.2022.943681.


Validation of the Anticolitis Efficacy of the Jian-Wei-Yu-Yang Formula.

Yan J, Tang Y, Yu W, Jiang L, Liu C, Li Q Evid Based Complement Alternat Med. 2022; 2022:9110704.

PMID: 36091591 PMC: 9451982. DOI: 10.1155/2022/9110704.


References
1.
Yoon S, Lee Y, Park S, Kim H, Bae H, Kim H . Anti-inflammatory effects of Scutellaria baicalensis water extract on LPS-activated RAW 264.7 macrophages. J Ethnopharmacol. 2009; 125(2):286-90. DOI: 10.1016/j.jep.2009.06.027. View

2.
Borghini S, Ferrera D, Prigione I, Fiore M, Ferraris C, Mirisola V . Gene expression profile in TNF receptor-associated periodic syndrome reveals constitutively enhanced pathways and new players in the underlying inflammation. Clin Exp Rheumatol. 2016; 34(6 Suppl 102):S121-S128. View

3.
Shin E, Kwon H, Kim Y, Shin H, Kim J . Chrysin, a natural flavone, improves murine inflammatory bowel diseases. Biochem Biophys Res Commun. 2009; 381(4):502-7. DOI: 10.1016/j.bbrc.2009.02.071. View

4.
Petrera E, Nittolo A, Alche L . Antiviral action of synthetic stigmasterol derivatives on herpes simplex virus replication in nervous cells in vitro. Biomed Res Int. 2014; 2014:947560. PMC: 4131461. DOI: 10.1155/2014/947560. View

5.
Garcia-Tobilla P, Solorzano S, Salido-Guadarrama I, Gonzalez-Covarrubias V, Morales-Montor G, Diaz-Otanez C . SFRP1 repression in prostate cancer is triggered by two different epigenetic mechanisms. Gene. 2016; 593(2):292-301. DOI: 10.1016/j.gene.2016.08.030. View